DEA Proposes To Extend Telemedicine Prescribing Flexibilities Authorized During COVID-19 Emergency

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

DEA Proposes To Extend Telemedicine Prescribing Flexibilities Authorized During COVID-19 Emergency

Dennis Tosh

February 27, 2023 at 08:55:03 ET

The DEA Feb. 24 issued two notices of proposed rulemaking (NPRMs) that would make permanent many telemedicine prescribing flexibilities that the agency has authorized during the COVID-19 public health emergency. The two NPRMs — “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation” (88 Fed. Reg. 12... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Proposes To Extend Telemedicine Prescribing Flexibilities Authorized During COVID-19 Emergency

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT